Chong Kun Dang Holdings Corp. (KRX:001630)

South Korea flag South Korea · Delayed Price · Currency is KRW
46,500
-1,250 (-2.62%)
Last updated: Apr 2, 2026, 2:28 PM KST
Market Cap222.56B +5.4%
Revenue (ttm)959.01B +0.1%
Net Income40.43B +20.3%
EPS8,422.78 +19.4%
Shares Out4.76M
PE Ratio5.55
Forward PEn/a
Dividend1,400.00 (2.93%)
Ex-Dividend DateMar 30, 2026
Volume4,429
Average Volume5,188
Open47,950
Previous Close47,750
Day's Range46,500 - 48,250
52-Week Range40,700 - 59,300
Beta0.59
RSI40.57
Earnings DateMay 15, 2026

About Chong Kun Dang Holdings

Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. Chong Kun Dang Holdings Corp. was founded in 1941 and is based in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1941
Employees 37
Stock Exchange Korea Stock Exchange
Ticker Symbol 001630
Full Company Profile

Financial Performance

In 2025, Chong Kun Dang Holdings's revenue was 959.01 billion, an increase of 0.13% compared to the previous year's 957.75 billion. Earnings were 40.43 billion, an increase of 20.34%.

Financial Statements